ANNUAL REPORT SOUTH CAROLINA COMMISSION FOR THE BLIND FISCAL YEAR 1981-1982

The South Carolina Commission for the Blind reports to the Office of the Governor its annual report that includes summaries, financial statements, organizational charts, and directories.

ANNUAL REPORT SOUTH CAROLINA COMMISSION FOR THE BLIND Fiscal Year 1982-83

The South Carolina Commission for the Blind reports to the Office of the Governor its annual report that includes summaries, financial statements, organizational charts, and directories.

ANNUAL REPORT SOUTH CAROLINA COMMISSION FOR THE BLIND Fiscal Year 1983-84

The South Carolina Commission for the Blind reports to the Office of the Governor its annual report that includes summaries, financial statements, organizational charts, and directories.

ANNUAL REPORT SOUTH CAROLINA COMMISSION FOR THE BLIND Fiscal Year 1984-85

The South Carolina Commission for the Blind reports to the Office of the Governor its annual report that includes summaries, financial statements, organizational charts, and directories.

SOUTH CAROLINA COMMISSION FOR THE BLIND ANNUAL REPORT 1985-1986

The South Carolina Commission for the Blind reports to the Office of the Governor its annual report that includes summaries, financial statements, organizational charts, and directories.

SOUTH CAROLINA COMMISSION FOR THE BLIND ANNUAL REPORT 1986-1987

The South Carolina Commission for the Blind reports to the Office of the Governor its annual report that includes summaries, financial statements, organizational charts, and directories.

SOUTH CAROLINA COMMISSION FOR THE BLIND ANNUAL REPORT 1987-1988

The South Carolina Commission for the Blind reports to the Office of the Governor its annual report that includes summaries, financial statements, organizational charts, and directories.

ANNUAL REPORT OF THE SOUTH CAROLINA COMMISSION FOR THE BLIND FOR THE FISCAL YEAR 1976-1977

The South Carolina Commission for the Blind reports to the Office of the Governor its annual report that includes summaries, financial statements, organizational charts, and directories.

ANNUAL REPORT SOUTH CAROLINA COMMISSION FOR THE BLIND 1977-1978

The South Carolina Commission for the Blind reports to the Office of the Governor its annual report that includes summaries, financial statements, organizational charts, and directories.

ANNUAL REPORT OF THE SOUTH CAROLINA COMMISSION FOR THE BLIND FOR THE FISCAL YEAR 1975-1976

The South Carolina Commission for the Blind reports to the Office of the Governor its annual report that includes summaries, financial statements, organizational charts, and directories.

Dietary nitrate modulates cerebral blood flow parameters and cognitive performance in humans : a double-blind, placebo-controlled, crossover investigation

A double blind trial of ketoprofen in the treatment of osteoarthritis of the hip

In a double blind study of ketoprofen and placebo in the treatment of osteoarthritis of the hip, ketoprofen was shown to be significantly more effective. Analysis of results was made using the sequential technique. Major intolerance occurred in two cases and minor intolerance in five cases. Newly diagnosed cases were treated more readily with ketoprofen than chronic cases treated for several months with other drugs which had proved ineffective. There were no changes in biological parameters. Age and sex did not affect the result. The further study of ketoprofen in large open trials appears to be indicated.

A Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus reuteri for Chronic Functional Abdominal Pain in Children

Background: Functional abdominal pain (FAP) is one of the most common diseases, and large percentages of children suffer from it. Objectives: The purpose of the study was to evaluate the effect of Lactobacillus reuteri in treatment of children with functional abdominal pain. Patients and Methods: This study was a randomized double-blind placebo-controlled trial. Children aged 4 to 16 years with chronic functional abdominal pain (based on Rome III criteria) were enrolled in the study. They were randomly divided into two groups, one receiving probiotic and the other placebo. Results: Forty children received probiotic and forty others placebo. There were no significant differences in age, weight, sex, location of pain, associated symptoms, frequency and intensity of pain between the groups. The severity and frequency of abdominal pain in the first month compared to baseline was significantly less and at the end of the second month, there was no significant difference between both groups compared to the end of the first month. Conclusions: This study showed that the severity of pain was significantly reduced in both groups. There was no significant difference in pain scores between them. The effect of probiotic and placebo can probably be attributed to psychological effect of the drugs.

Oral Zinc Sulfate as Adjuvant Treatment in Children With Nephrolithiasis: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Background: Nephrolithiasis in children is associated with a high rate of complications and recurrence. Objectives:Since some evidences reported that zinc has an important place amongst inhibitors of crystallization and crystal growth, we decided to assess the effectiveness of oral zinc sulfate as adjuvant treatment in children with nephrolithiasis. Patients and Methods: This was a randomized, double-blind, placebo-controlled clinical trial. 102 children in the age range 1 month to 11 years with first nephrolithiasis were recruited. Patients were randomly divided into two equal groups (intervention and control groups). Intervention group received conservative measures for stones and 1 mg/kg/day (maximum 20 mg/day) oral zinc sulfate syrup for 3 months. Control group received placebo in addition to conservative measures, also for 3 months. Patients were followed up by ultrasonography for 9 months, in 5 steps (at the end of 1st, 2nd, 3rd, 6th and 9th month after treatment) assessing size and number of stones in the kidneys. Results: Only at the end of the first month, the average number (intervention: 1.15 ± 3.78, control: 1.3 ± 2.84) (P = 0.001) and size (cm) (intervention: 0.51 ± 1.76, control: 0.62 ± 1.39) (P = 0.001) of stones was significantly lower in the intervention group, and in other points there was no significant therapeutic efficacy in oral zinc adjuvant treatment compared to conservative treatment alone. Also, during the 9-month follow-up, the number and size of stones in both groups decreased significantly (both: P < 0.0001) in a way that the decrease in the intervention group showed no difference with the control group. Conclusions: Adjuvant treatment with zinc is not more effective than consecutive treatment in children with nephrolithiasis. However, further studies are recommended due to the lack of clinical evidence in this field.

A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS

In an aging western population, a significant number of patients continue to suffer from angina once all revascularization and optimal medical treatment options are exhausted. Under experimental conditions, oral supplementation with inorganic nitrate was shown to exhibit a blood pressure-lowering effect, and has also been shown to promote angiogenesis, improve endothelial dysfunction and mitochondrial efficiency in skeletal muscle. It is unknown whether similar changes occur in cardiac muscle. In the current study, we investigate whether oral sodium nitrate treatment will improve myocardial ischemia in patients with stable angina.